Technical Analysis for TCRT - Alaunos Therapeutics, Inc.

Grade Last Price % Change Price Change
F 2.04 -0.49% -0.01
TCRT closed down 0.49 percent on Friday, November 1, 2024, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion -0.49%
Wide Bands Range Expansion -0.49%
Oversold Stochastic Weakness -0.49%
New 52 Week Closing Low Bearish 1.00%
Narrow Range Bar Range Contraction 1.00%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 20 hours ago
Possible Inside Day about 20 hours ago
Down 1% 1 day ago
Rose Above Previous Day's High 2 days ago
10 DMA Resistance 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Alaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has clinical and strategic collaborations with The University of Texas MD Anderson Cancer Center and the National Cancer Institute.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cell Therapy Epidermal Growth Factor Receptor Oncogenes National Cancer Institute P53 Ras Gtpase Tumor Suppressor Genes University Of Texas Md Anderson Cancer Center

Is TCRT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.85
52 Week Low 2.0
Average Volume 20,142
200-Day Moving Average 10.09
50-Day Moving Average 2.57
20-Day Moving Average 2.22
10-Day Moving Average 2.14
Average True Range 0.21
RSI (14) 39.76
ADX 11.85
+DI 23.19
-DI 23.96
Chandelier Exit (Long, 3 ATRs) 2.47
Chandelier Exit (Short, 3 ATRs) 2.63
Upper Bollinger Bands 2.56
Lower Bollinger Band 1.88
Percent B (%b) 0.24
BandWidth 30.61
MACD Line -0.18
MACD Signal Line -0.18
MACD Histogram -0.0028
Fundamentals Value
Market Cap 32.73 Million
Num Shares 16 Million
EPS -2.25
Price-to-Earnings (P/E) Ratio -0.91
Price-to-Sales 2277.94
Price-to-Book 2.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.07
Resistance 3 (R3) 2.07 2.05 2.07
Resistance 2 (R2) 2.05 2.05 2.06 2.06
Resistance 1 (R1) 2.05 2.04 2.05 2.05 2.06
Pivot Point 2.03 2.03 2.04 2.04 2.03
Support 1 (S1) 2.03 2.03 2.03 2.03 2.02
Support 2 (S2) 2.01 2.02 2.02 2.02
Support 3 (S3) 2.01 2.01 2.02
Support 4 (S4) 2.01